Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Microbix Biosystems Inc T.MBX

Alternate Symbol(s):  MBXBF

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency... see more

TSX:MBX - Post Discussion

Microbix Biosystems Inc > Adelaide Update
View:
Post by wizzdumb on Dec 21, 2021 1:31pm

Adelaide Update

Video just posted. Highlights (Cameron on at about 15 minute mark):

- high teens for rev for 2021 (no surprise)
- 25-30M for 2022

Qaps and VTM buildout will provide capacity for $4M each per month so possibility for $8M per month once completed and fully burdened!! That's huge. 

Add in a Kinlytic deal early 2022 and we should be happy. 


https://youtu.be/k1RMdUhvZ7Y

Comment by mercedesman on Dec 21, 2021 4:10pm
Good stuff. Production ramp-up, once done will increase both Qaps and VTM output by 5 to 10 X current rate. My guess is that we are a ways until that happens otherwise 2021 revenues would be much higher than $25-$30M...although the ramp-up in capacity could take several months or quarters yet. Three comments: - IMO he is being conservative (probably as to start date of higher capacity output) ...more  
Comment by wizzdumb on Dec 21, 2021 5:16pm
Based on previous guidance I believe it's about June 2022 before the expansion will be complete. Obviously it won't be an on/off situation so should start seeing increased production from current slightly before that. This aligns with top line forecast for Q4   2022 to be in the 17-18M range. Run that out into FY2023 and we could be seeing top line number something in the 80-100M ...more  
Comment by RazeKreations on Dec 21, 2021 7:31pm
That is pretty incredible growth forecast going forward. And anybody that has been following Microbix knows that when Cameron Groome makes a statement it is usually on the conservative side. He does not like overstating growth. Sure glad that i am in on this ride. It is going to be fun. Once the fiscal year end is posted on Thursday i believe that will put more fuel on the fire. MBX is heating up. ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities